Biochemistry, Genetics and Molecular Biology
Proteomics
100%
Proteogenomics
51%
Mass Spectrometry
33%
Microarrays
20%
Immunoassay
18%
Proteome
17%
Gene Expression
16%
Glycoproteomics
16%
Prostate-Specific Antigen
16%
Surface-Enhanced Laser Desorption/Ionization
15%
Glycoprotein
13%
Glycosylation
13%
Surface Property
13%
Time-of-Flight Mass Spectrometry
12%
Cancer Cell
12%
CA-125
12%
CA19-9
10%
Tumor Antigen
10%
Tumor Marker
9%
Signal Transduction
8%
Liquid Chromatography-Mass Spectrometry
8%
Posttranslational Modification
8%
Plasma Protein
8%
Chromosome Instability
8%
Phosphoproteomics
7%
Gleason Score
7%
Protein Expression
7%
Tandem Mass Spectrometry
7%
Acetylation
6%
Protein Glycosylation
6%
Membrane Microparticle
6%
Quantitative Proteomics
6%
DNA Methylation
6%
Epigenetics
6%
Methylation
6%
Lectin
5%
Mouse
5%
Gene Expression Profiling
5%
Volume
5%
Desorption
5%
Colon
5%
Solution and Solubility
5%
Marker Gene
5%
Gene Control
5%
P53
5%
Subtyping
5%
Molecular Network
5%
Protein Microarray
5%
Receptor Tyrosine Kinase
5%
RNA Sequence
5%
Medicine and Dentistry
Proteomics
42%
Biological Marker
41%
Ovarian Cancer
40%
CA-125
36%
Prostate Cancer
26%
Cancer
20%
Proteogenomics
16%
Neoplasm
16%
Tumor Marker
15%
Adnexal Mass
15%
Disease
13%
Krukenberg Tumor
11%
Patient Referral
10%
Tumor Antigen
10%
Malignant Neoplasm
9%
Ovarian Tumor
9%
Risk Stratification
8%
Pelvis
8%
Breast Cancer
7%
Ovarian Cancer Screening
7%
Cancer Diagnosis
6%
Lung Cancer Screening
6%
Colorectal Cancer Screening
6%
Premature Labor
6%
Urology
6%
Disease Process
6%
Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry
6%
Urinary System
6%
Membrane Microparticle
6%
Clear Cell Renal Cell Carcinoma
6%
CA 15-3
6%
Prostate Specific Antigen
6%
Transthyretin
5%
Sensitivity and Specificity
5%
Clinical Assessment
5%
Colony Stimulating Factor 1
5%
Keyphrases
Proteogenomics
23%
Carbohydrate Antigen 125 (CA125)
22%
Multivariate Index Assay
16%
Prostate Cancer
14%
Ovarian Cancer
14%
Aggressive Prostate Cancer
13%
Early Detection
12%
Glycoprotein
10%
Artificial Neural Network
10%
Ovarian Tumor
10%
Clear Cell Renal Cell Carcinoma (ccRCC)
10%
Early-stage Ovarian Cancer
9%
Surface-enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry (SELDI-TOF-MS)
8%
Disease Process
8%
Biotechnology
8%
Proteomics
8%
Serum Markers
8%
Proteomic Analysis
7%
Epithelial Ovarian Cancer
7%
Gynecologist
7%
Obstetricians
7%
Clinical Proteomic Tumor Analysis Consortium
7%
Prostate Cancer Screening
7%
Serum Samples
7%
Glycoproteomics
7%
Adnexal Mass
6%
Carbohydrate Antigen 19-9 (CA19-9)
6%
Statistical Methods
6%
High-throughput Genomics
6%
Biomedical Research
6%
Genomic Profiling
6%
Small Size Sample
6%
Serum Proteomic Profiling
6%
Pancreatic Ductal Adenocarcinoma
6%
Microarray
6%
Common Objective
6%
Proteomic Biomarkers
6%
Expression Level
6%
Expression Data
6%
Profiling Technology
6%
Simultaneous Analysis
6%
Clinical Research
6%
Malignancy Risk Stratification
6%
Confidence Interval
6%
Tumor
6%
American Colleges
5%
Post-translational Modification
5%
Malignancy
5%
Breast Cancer
5%
Immunoassay
5%
